DTRTW
DTRT Health Acquisition Corp. [DTRTW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DTRTW Stock Summary
In the News
DTRTW Financial details
Company Rating
Sell
Market Cap
0
Income
27.21M
Revenue
0
Book val./share
-0.48
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
30.18
Forward P/E
-
PEG
-
P/S
-
P/B
-21.48
P/C
-
P/FCF
-
Quick Ratio
0.13
Current Ratio
1.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.35
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-152.22%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
3%
ROE
5%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.0E-4-0.001
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
DTRTW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2021-12-31 |
|---|---|---|
| 2.02K | ||
| Revenue per share | 0 | |
| Net income per share | 0.36 | |
| Operating cash flow per share | -0.04 | |
| Free cash flow per share | -0.04 | |
| Cash per share | 0.01 | |
| Book value per share | -0.45 | |
| Tangible book value per share | 7.71 | |
| Share holders equity per share | -0.45 | |
| Interest debt per share | -0.19 | |
| Market cap | 286.93M | |
| Enterprise value | 286.58M | |
| P/E ratio | 28.1 | |
| Price to sales ratio | 0 | |
| POCF ratio | -250.28 | |
| PFCF ratio | -250.28 | |
| P/B Ratio | -22.13 | |
| PTB ratio | -22.13 | |
| EV to sales | 0 | |
| Enterprise value over EBITDA | 59.01 | |
| EV to operating cash flow | -249.98 | |
| EV to free cash flow | -249.98 | |
| Earnings yield | 0.04 | |
| Free cash flow yield | 0 | |
| Debt to equity | 0 | |
| Debt to assets | 0 | |
| Net debt to EBITDA | -0.07 | |
| Current ratio | 3.88 | |
| Interest coverage | 0.09 | |
| Income quality | -0.24 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0 | |
| Capex to operating cash flow | 0 | |
| Capex to revenue | 0 | |
| Capex to depreciation | 0 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 1.9 | |
| ROIC | 0.08 | |
| Return on tangible assets | 0.04 | |
| Graham Net | -0.48 | |
| Working capital | 893.12K | |
| Tangible asset value | 221.64M | |
| Net current asset value | -12.98M | |
| Invested capital | 0 | |
| Average receivables | 0 | |
| Average payables | 0 | |
| Average inventory | 0 | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 0 | |
| Days of inventory on hand | 0 | |
| Receivables turnover | 0 | |
| Payables turnover | 0 | |
| Inventory turnover | 0 | |
| ROE | -0.79 | |
| Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.42 | 1.74 | 0.52 | 0.18 | -0.09 | |
| Operating cash flow per share | -0.2 | -0.1 | -0.02 | -0.01 | -0.01 | |
| Free cash flow per share | -0.2 | -0.1 | -0.02 | -0.01 | -0.01 | |
| Cash per share | 0.13 | 0.03 | 0.01 | 0.01 | 0 | |
| Book value per share | 18.94 | -1.16 | -0.91 | -0.36 | -0.48 | |
| Tangible book value per share | 18.94 | 19.8 | 20.04 | 9.84 | 9.74 | |
| Share holders equity per share | 18.94 | -1.16 | -0.91 | -0.36 | -0.48 | |
| Interest debt per share | 0 | -0.89 | -0.27 | -0.09 | 0.07 | |
| Market cap | 110.95M | 111.73M | 112.29M | 231.5M | 233.68M | |
| Enterprise value | 109.49M | 111.39M | 112.13M | 231.34M | 233.61M | |
| P/E ratio | -5.89 | 1.43 | 4.83 | 14.3 | -27.03 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -50.74 | -97.46 | -537.7 | -1.35K | -1.98K | |
| PFCF ratio | -50.74 | -97.46 | -537.7 | -1.35K | -1.98K | |
| P/B Ratio | 0.52 | -8.62 | -11 | -27.85 | -21.11 | |
| PTB ratio | 0.52 | -8.62 | -11 | -27.85 | -21.11 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -23.24 | 11.64 | 40.69 | 121.96 | -122.63 | |
| EV to operating cash flow | -50.07 | -97.16 | -536.9 | -1.35K | -1.98K | |
| EV to free cash flow | -50.07 | -97.16 | -536.9 | -1.35K | -1.98K | |
| Earnings yield | -0.04 | 0.17 | 0.05 | 0.02 | -0.01 | |
| Free cash flow yield | -0.02 | -0.01 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0.31 | -0.04 | -0.06 | -0.08 | 0.04 | |
| Current ratio | 2.01 | 3.88 | 2.96 | 3.09 | 1.07 | |
| Interest coverage | 0 | 0.04 | 0.1 | 0.12 | -0.16 | |
| Income quality | 1 | -0.12 | -0.08 | -0.09 | 0.05 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 13.39 | 6.74 | 3.27 | 1.2 | 1.01 | |
| ROIC | 0 | 0.06 | 0.06 | 0.07 | 0.03 | |
| Return on tangible assets | -0.02 | 0.08 | 0.02 | 0.02 | -0.01 | |
| Graham Net | -2.11 | -1.24 | -0.98 | -0.39 | -0.52 | |
| Working capital | 1.26M | 893.12K | 620.16K | 530K | 37.15K | |
| Tangible asset value | 212.02M | 221.64M | 224.39M | 226.29M | 224.13M | |
| Net current asset value | -22.59M | -12.98M | -10.23M | -8.3M | -11.48M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 545.79K | 514.88K | 36.8K | 49.07K | 32.14K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.02 | -1.5 | -0.57 | -0.49 | 0.2 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
DTRTW Frequently Asked Questions
What is DTRT Health Acquisition Corp. stock symbol ?
DTRT Health Acquisition Corp. is a US stock , located in Oak brook of Il and trading under the symbol DTRTW
What is DTRT Health Acquisition Corp. stock quote today ?
DTRT Health Acquisition Corp. stock price is $- today.
Is DTRT Health Acquisition Corp. stock public?
Yes, DTRT Health Acquisition Corp. is a publicly traded company.
Company Profile
- Headquarters Oak Brook,IL,US
- IPO Date 2021-10-25
-
Website
http://www.dtrthealth.com 
DTRT Health Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was incorporated in 2021 and is based in Oak Brook, Illinois.
